A. Galid
Impact in
- Oncology top 5%
- Neutropenia and Cancer Infections
- Bone health and treatments
- Inflammatory Biomarkers in Disease Prognosis
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 7
- Neutropenia and Cancer Infections 2
- Bone health and treatments 1
- Cancer survivorship and care 1
-
- Breast Cancer Treatment Studies 4
- Co-authors
- Michael Gnant (4 shared papers)Vicente Guillém (1 shared paper)H. Samonigg (1 shared paper)Roy Iqbal Lalisang (1 shared paper)R. Jakesz (3 shared papers)Salvatore Siena (1 shared paper)Martine J Piccart (1 shared paper)Bertrand C. Liang (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Current Medical Research and Opinion (3 papers)Journal of Clinical Oncology (3 papers)Thrombosis and Haemostasis (1 paper)Drugs of today (1 paper)
- Partner nations
- AustriaBelgiumNetherlands
In The Last Decade
A. Galid
23 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 68
- Oncology 743
- Cancer Research 165
- Orthopedics and Sports Medicine 97
- Hematology 102
- Pulmonary and Respiratory Medicine 113
Countries citing papers authored by A. Galid
This map shows the geographic impact of A. Galid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Galid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Galid more than expected).
Fields of papers citing papers by A. Galid
This network shows the impact of papers produced by A. Galid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Galid. The network helps show where A. Galid may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Galid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 515 | |
| 2 | 2006 | 269 | |
| 3 | 2003 | 137 | |
| 4 | 2015 | 106 | |
| 5 | 2006 | 84 | |
| 6 | 2007 | 76 | |
| 7 | 2004 | 30 | |
| 8 | 2018 | 20 | |
| 9 | 1999 | 8 | |
| 10 | 2019 | 8 | |
| 11 | 2012 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 1998 | 5 | |
| 14 | 2011 | 5 | |
| 15 | 2012 | 5 | |
| 16 | 2015 | 5 | |
| 17 | 2003 | 4 | |
| 18 | 1998 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2016 | 2 |
About A. Galid
A. Galid is a scholar working on Oncology, Cancer Research, Hematology, Pulmonary and Respiratory Medicine and Genetics, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Erythropoietin and Anemia Treatment (3 papers), Advanced Breast Cancer Therapies (3 papers), Estrogen and related hormone effects (2 papers), Neutropenia and Cancer Infections (2 papers), Bone health and treatments (1 paper), Nitric Oxide and Endothelin Effects (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Oncology (743 citations), Cancer Research (165 citations), Orthopedics and Sports Medicine (97 citations), Hematology (102 citations) and Pulmonary and Respiratory Medicine (113 citations). A. Galid has collaborated with scholars based in Austria, Belgium and Netherlands. Frequent co-authors include Michael Gnant, Vicente Guillém, H. Samonigg, Roy Iqbal Lalisang, R. Jakesz, Salvatore Siena, Martine J Piccart, Bertrand C. Liang, M. D. Green and Heinz Koelbl. Their work appears in journals such as Annals of Oncology, Current Medical Research and Opinion, Journal of Clinical Oncology, Thrombosis and Haemostasis and Drugs of today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.